← Back to Clinical Trials
Recruiting NCT06710301

NCT06710301 Cortical Correlates of Spatial Navigation Skills in an Immersive Virtual Reality Environment

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06710301
Status Recruiting
Phase
Sponsor IRCCS Eugenio Medea
Condition Cerebral Palsy (CP)
Study Type INTERVENTIONAL
Enrollment 70 participants
Start Date 2024-11-14
Primary Completion 2026-09-30

Eligibility & Interventions

Sex All sexes
Min Age 8 Years
Max Age 17 Years
Study Type INTERVENTIONAL
Interventions
Preliminary assessmentNavigation task with EEG recording

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 70 participants in total. It began in 2024-11-14 with a primary completion date of 2026-09-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this study is to investigate the neural mechanisms that undergoes spatial navigation skills in children/adolescents aged between 8 and 17 years. These skills play an important role in daily life, as they allow us to orient ourselves in familiar and unfamiliar environments, locate objects, interact with them and memorize their position. Navigation abilities vary widely between individuals, change with age and might be affected by diseases, such as the cerebral palsy (CP). Previous studies have, in fact, demonstrated differences in the learning and adaptation methods of spatial navigation skills in children affected by CP compared to typically developing (TD) peers. Through the use of the electroencephalogram (EEG) we want to shed light on the mechanisms that govern this ability with the aim of: 1. better characterize spatial navigation skills in children/adolescents, both TD and affected by CP; 2. investigate the origin of the differences found between the spatial navigation skills of TD children and those affected by CP, improving knowledge of the pathology and thus allowing, in the future, to identify more adequate rehabilitation interventions.

Eligibility Criteria

Inclusion Criteria: * typically developing subjects aged between 8 and 17 years; * subjects with CP aged between 8 and 17 years; Exclusion Criteria: * subjects aged under 8 or over 17 years; * subjects with epileptic problems; * subjects with poor head control; * subjects with visual problems that can not be corrected with prescription lens;

Contact & Investigator

Central Contact

Emilia Biffi

✉ emilia.biffi@lanostrafamiglia.it

📞 +39031877862

Frequently Asked Questions

Who can join the NCT06710301 clinical trial?

This trial is open to participants of all sexes, aged 8 Years or older, up to 17 Years, studying Cerebral Palsy (CP). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06710301 currently recruiting?

Yes, NCT06710301 is actively recruiting participants. Contact the research team at emilia.biffi@lanostrafamiglia.it for enrollment information.

Where is the NCT06710301 trial being conducted?

This trial is being conducted at Bosisio Parini, Italy, Conegliano, Italy.

Who is sponsoring the NCT06710301 clinical trial?

NCT06710301 is sponsored by IRCCS Eugenio Medea. The trial plans to enroll 70 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology